Report cover image

Dental Bone Graft Substitutes and Regenerative Materials Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Publisher GlobalData
Published Dec 16, 2022
Length 98 Pages
SKU # GBDT17643606

Description

Dental Bone Graft Substitutes and Regenerative Materials Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Summary

GlobalData's Medical Devices sector report, “Dental Bone Graft Substitutes & Regenerative Materials Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update provides comprehensive information about the Dental Bone Graft Substitutes & Regenerative Materials pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Dental bone grafts and substitutes are used to augment or fill a defect created by surgery, trauma, disease or developmental deficiency.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Dental Bone Graft Substitutes & Regenerative Materials under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Dental Bone Graft Substitutes & Regenerative Materials and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Dental Bone Graft Substitutes & Regenerative Materials under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

98 Pages
  • About GlobalData
    • Dental Bone Graft Substitutes & Regenerative Materials Overview
    • Dental Bone Graft Substitutes & Regenerative Materials - Pipeline Products by Stage of Development
    • Dental Bone Graft Substitutes & Regenerative Materials - Pipeline Products by Segment
    • Dental Bone Graft Substitutes & Regenerative Materials - Pipeline Products by Territory
    • Dental Bone Graft Substitutes & Regenerative Materials - Pipeline Products by Regulatory Path
    • Dental Bone Graft Substitutes & Regenerative Materials - Pipeline Products by Estimated Approval Date
    • Dental Bone Graft Substitutes & Regenerative Materials - Ongoing Clinical Trials
    • Dental Bone Graft Substitutes & Regenerative Materials Companies - Pipeline Products by Stage of Development
    • Dental Bone Graft Substitutes & Regenerative Materials - Companies Pipeline Products by Stage of Development
    • 3-D Matrix Ltd Company Overview
    • Advanced Biotech Products Pvt Ltd Company Overview
    • Cayman Chemical Co Company Overview
    • CellSeed Inc Company Overview
    • Colorado Therapeutics, LLC Company Overview
    • credentis AG Company Overview
    • curasan AG Company Overview
    • Fujifilm Corp Company Overview
    • Histocell SL Company Overview
    • Indian Institute of Technology Bombay Company Overview
    • Induce Biologics Inc. Company Overview
    • Ivory Graft Ltd Company Overview
    • Malla Reddy Institute of Medical Sciences Company Overview
    • Maxigen Biotech Inc Company Overview
    • Medtronic Plc Company Overview
    • Nobel Biocare Services AG Company Overview
    • Novatissue SAS Company Overview
    • Orthocell Ltd Company Overview
    • Orthogen LLC Company Overview
    • Orthorebirth Co Ltd Company Overview
    • Orthosera GmbH Company Overview
    • PolyPid Ltd Company Overview
    • Polytechnic University of Catalonia Company Overview
    • RevBio Inc Company Overview
    • Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
    • Straumann Holding AG Company Overview
    • SurgaColl Technologies Ltd Company Overview
    • SweetBio, Inc. Company Overview
    • Tetratherix Pty Ltd Company Overview
    • Tigran Technologies AB Company Overview
    • University of Bielefeld Company Overview
    • University of Connecticut Health Center Company Overview
    • University of Maryland Company Overview
    • ZetaGen Therapeutics Inc Company Overview
    • Dec 01, 2022: CollPlant Biotechnologies Provides Business Updates and Third Quarter 2022 Financial Results
    • Nov 23, 2022: Medtronic Reports Quarterly Earnings
    • Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results
    • Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday
    • Nov 14, 2022: Dentsply Sirona Reports Third Quarter 2022 Results
    • Oct 04, 2022: Exactech Names New Chief Financial Officer
    • Sep 07, 2022: Medtronic to appear at September investor conferences
    • Aug 25, 2022: Collplant Biotechnologies Provides Business Updates and Second Quarter 2022 Financial Results
    • Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results
    • Aug 23, 2022: Medtronic Announces Quarterly Earnings Results
    • Aug 17, 2022: Sven Weiler joins Endogena as VP Medicinal Chemistry
    • Aug 02, 2022: Zimmer Biomet Announces Second Quarter 2022 Financial Results
    • Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director
    • Jun 16, 2022: MIchael Lai joins Endogena as Medical Director
    • Jun 04, 2022: Moreno Menghini appointed Chief Medical Officer
    • May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results
    • May 26, 2022: CollPlant Biotechnologies Provides Business Updates and First Quarter 2022 Financial Results
    • May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase
    • May 18, 2022: Dentsply Sirona Receives Notice of Filing Delinquency from Nasdaq
    • May 16, 2022: Zimmer Biomet Announces Appointment of New Chief Accounting Officer
    • May 11, 2022: Sygnature Discovery to deploy Iktos's AI for drug design software Makya
    • May 03, 2022: Zimmer Biomet Announces First Quarter 2022 Financial Results
    • Apr 13, 2022: CollPlant To Present at the Aesthetics Innovation Summit 2022
    • Mar 24, 2022: CollPlant Biotechnologies Provides Business Updates and Fiscal Year 2021 Financial Results
    • Mar 08, 2022: Straumann Holding announce Invitation of half-year financial results webcast
    • Feb 15, 2022: Straumann Group reports revenue exceeding CHF 2 billion
    • Feb 04, 2022: Straumann Group announces invitation for 2021 full-year financial results webcast
    • Jan 25, 2022: Medprin Regenerative Medical Technologies Announces on the resignation of the company's director and board secretary
    • Jan 21, 2022: Zimmer Biomet Announces Filing of Form 10 Registration Statement in Connection with Planned Spinoff of ZimVie; ZimVie to Host Investor Day on February 7
    • Jan 07, 2022: Collagen Matrix Names Tony Orsini Chief Operating Officer
    • Jan 04, 2022: Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
    • Dec 21, 2021: Maipu Medical Announcement on Appointment of Deputy General Manager of the Company
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us